![Pharmacology / Clinical research / Design of experiments / Clinical trial / Drug discovery / Pharmaceutical industry / Irritable bowel syndrome / Food and Drug Administration / Linaclotide / Health / Medicine / Pharmaceutical sciences Pharmacology / Clinical research / Design of experiments / Clinical trial / Drug discovery / Pharmaceutical industry / Irritable bowel syndrome / Food and Drug Administration / Linaclotide / Health / Medicine / Pharmaceutical sciences](https://www.pdfsearch.io/img/f89e9c958d50c2c1872540b276c3f9c5.jpg)
| Document Date: 2011-08-15 11:58:27 Open Document File Size: 16,51 KBShare Result on Facebook
City SAN DIEGO / / Company Tioga Pharmaceuticals Inc. / Special Protocol Assessments An SPA / Tioga Pharmaceuticals Tioga Pharmaceuticals Inc. / Tioga Pharmaceuticals / / Country United States / / Event FDA Phase / / Facility About Special Protocol Assessments An SPA / / IndustryTerm efficacy protocols / pharmaceutical / / MedicalCondition diarrhea-predominant irritable bowel syndrome / pain / gastrointestinal diseases / bloating / / Organization FDA / U.S. Food and Drug Administration / / Person Allen Mangel / / Position Chief Medical Officer / / Product only one drug / Asimadoline / / ProvinceOrState California / / Technology 3 efficacy protocols / / URL www.tiogapharma.com / /
SocialTag |